Bora Pharmaceuticals Co., Ltd.
6472
Rank in Stocks
#6921
Globally, Bora Pharmaceuticals Co., LTD. is engaged in the comprehensive... Globally, Bora Pharmaceuticals Co., LTD. is engaged in the comprehensive lifecycle of pharmaceutical products, encompassing research and development, manufacturing, distribution, and sales. The organization operates through key divisions, including Sales, Contract Development & Manufacturing Organization (CDMO), and other ancillary services. Bora produces and markets a diverse range of medicines, from generic and proprietary brand-name drugs to over-the-counter (OTC) remedies. Beyond its in-house portfolio, the company provides extensive contract development and manufacturing solutions. These CDMO services cover all stages of pharmaceutical development, clinical and commercial production, specialized packaging and serialization, rigorous analytical and microbiological quality control, and expert guidance on regulatory compliance. Furthermore, Bora's offerings extend to nutritional supplements, skincare products, and various biotechnical services. The company distributes its goods directly to healthcare facilities such as clinics, pharmacies, and pharmacy chains, as well as to drugstores. It also leverages distributors to supply larger institutions like medical centers, corporate and public hospitals, and regional and district hospitals. Established in 2007, Bora Pharmaceuticals Co., LTD. is based in Taipei City, Taiwan.
Share Price
$12.01
Last synced: 2026-11-10
Market Cap
$1.53B
Change (1 day)
-3.67%
Change (1 year)
-40.54%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bora Pharmaceuticals Co., Ltd. (6472)
Category
Healthcare
Operating Margin for Bora Pharmaceuticals Co., Ltd. (6472)
Operating Margin as of November 2026 TTM: 15.41%
According to Bora Pharmaceuticals Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 15.41%. At the end of 2025 the company had an operating margin of 17.32%.
Operating Margin history for Bora Pharmaceuticals Co., Ltd. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 15.41% | -11.03% |
| 2025 | 17.32% | -1.48% |
| 2024 | 17.58% | -52.45% |
| 2023 | 36.97% | 99.08% |
| 2022 | 18.57% | -15.55% |
| 2021 | 21.99% | 72.47% |
| 2020 | 12.75% | -43.46% |
| 2019 | 22.55% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -98.74% |
DE
|
|
| 19.68% | -98.72% |
DE
|
|
| 13.26% | -99.14% |
JP
|
|
| 17.08% | -98.89% |
CH
|
|
| 14.92% | -99.03% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Bora Pharmaceuticals Co., Ltd.'s operating margin
What is Bora Pharmaceuticals Co., Ltd.'s operating margin?
Bora Pharmaceuticals Co., Ltd.'s operating margin is 15.41%, as of Nov 2026.
What was Bora Pharmaceuticals Co., Ltd.'s operating margin in 2025?
In 2025, Bora Pharmaceuticals Co., Ltd.'s operating margin was 17.32%, compared with 17.58% in 2024.
How has Bora Pharmaceuticals Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Bora Pharmaceuticals Co., Ltd.'s operating margin was highest in 2023 (36.97%) and lowest in 2020 (12.75%).
How does Bora Pharmaceuticals Co., Ltd.'s operating margin compare with similar companies?
Bora Pharmaceuticals Co., Ltd.'s operating margin (15.41%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.